<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791488</url>
  </required_header>
  <id_info>
    <org_study_id>2019PBMD05</org_study_id>
    <nct_id>NCT04791488</nct_id>
  </id_info>
  <brief_title>Impact of Hyperoxia and Involvement of the Immune System in Diving Accident</brief_title>
  <acronym>OXYDIVE</acronym>
  <official_title>Impact of Hyperoxia and Involvement of the Immune System in Diving Accident</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Direction Centrale du Service de Santé des Armées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Direction Centrale du Service de Santé des Armées</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of oxygen therapy in many pathologies has been subject of recent work, arguing&#xD;
      both favourable and harmful effects. Consequently, one can wonder about the influence of&#xD;
      hyperoxic gas mixture during diving on the genesis of decompression sickness, but also about&#xD;
      the systematic application of normobaric and hyperbaric oxygen in case of proven&#xD;
      decompression sickness.&#xD;
&#xD;
      In mammals, normoxic concentrations have been redefined at 20-100 mbars at the extracellular&#xD;
      level and below 10 mbars in the mitochondria.&#xD;
&#xD;
      Under hyperbaric conditions, most of the oxygen being dissolved in blood plasma, a state of&#xD;
      hyperoxia is established which escapes the usual delivery and regulation system represented&#xD;
      by red blood cells.&#xD;
&#xD;
      The results of our team's previous work suggest a specific effect of diving on the levels of&#xD;
      circulating mitochondrial DNA (mtDNA), suggesting cellular destruction linked to&#xD;
      hyperoxia/hyperbaria. In fact, our studies, carried out on both animals and human divers,&#xD;
      have shown that diving accident leads to an increase in mtDNA levels and an immune reaction&#xD;
      through the mobilisation of leukocytes.&#xD;
&#xD;
      The main objective of this study is to compare the influence of oxygen partial pressure&#xD;
      levels on the evolution of clinical and biological variables during hyperbaric oxygen therapy&#xD;
      sessions in healthy versus injured divers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">October 2027</completion_date>
  <primary_completion_date type="Anticipated">October 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of decompression sickness clinical symptoms</measure>
    <time_frame>Until the end of the oxygen therapy treatment (up to 1 year)</time_frame>
    <description>Decompression sickness clinical symptoms will be assessed through a medical examination after each hyperbaric session.&#xD;
Decompression sickness clinical symptoms include: paresthesia, sensory deficit, motor deficit, spinal pain, sphincter disorder and brain injury.&#xD;
The evolution of symptoms will be rated as following: total regression, improvement, stabilization, fluctuation or worsening</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">265</enrollment>
  <condition>Decompression Sickness</condition>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Decompression sickness patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperbaric oxygen therapy</intervention_name>
    <description>Hyperbaric oxygen therapy protocol</description>
    <arm_group_label>Decompression sickness patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Diving simulation</intervention_name>
    <description>Hyperbaric chamber diving simulation protocol</description>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy subject with no contraindications to diving OR patient admitted to the&#xD;
             hospital for suspicion of a diving accident OR patient admitted to the hospital for&#xD;
             hyperbaric oxygen therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to diving or contraindication to hyperbaric oxygen therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicolas VALLEE, PhD</last_name>
    <phone>483162849</phone>
    <phone_ext>+33</phone_ext>
    <email>nicolas.vallee@intradef.gouv.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital d'Instruction des Armées Sainte-Anne</name>
      <address>
        <city>Toulon</city>
        <zip>83800</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicolas VALLEE, PhD</last_name>
      <phone>483162849</phone>
      <phone_ext>+33</phone_ext>
      <email>nicolas.vallee@intradef.gouv.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sarah RIVES, MF</last_name>
      <phone>483163666</phone>
      <phone_ext>+33</phone_ext>
      <email>sarah.rives@intradef.gouv.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 13, 2020</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperoxia</mesh_term>
    <mesh_term>Decompression Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

